$MDAI Balance Sheet | Understand Stock

$MDAI

$1.53 +$0.03 (2.0%) Close

$MDAI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Unaudited Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash
Cash and cash equivalents
Accounts receivable, net
Inventory
Unbilled revenue
Deferred offering costs
Prepaid expenses
Other current assets
Total current assets

Investment held in Trust Account
Cash held in Trust Account
Non-current assets:
Property and equipment, net
Right-of-use assets
Other assets
Total Assets

Liabilities and Stockholders’ Equity (Deficit)
Current liabilities:
Income taxes payable
Due to Sponsor
Accounts payable
Accrued expenses
Accrued offering costs
Deferred revenue
Lease liabilities, short-term
Notes payable
Notes payable – at fair value
Notes payable - related party
Warrant liabilities
Total current liabilities

Warrant liabilities
Warrant liabilities
Deferred underwriting fee payable
Notes payable - related party
Notes payable, long-term
Lease liabilities, long-term
Total Liabilities
Class A common stock subject to possible redemption: 458,716 shares at approximately $10.58 and $10.44 per share redemption value at June 30, 2023 and December 31, 2022, respectively

Stockholders’ Deficit
Preferred stock ($0.0001 par value); 1,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common stock ($0.0001 par value); 80,000,000 shares authorized; 32,184,928 and 30,688,895 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Common Class A
Common Class B
Total common stock ($0.0001 par value); 80,000,000 shares authorized; 32,184,928 and 30,688,895 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively

Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 6,325,000 shares issued and outstanding at June 30, 2023 and December 31, 2022
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total Stockholders’ Deficit

Total Liabilities and Stockholders’ Deficit

Comments